JBIO (Jade Biosciences) OCF Margin %: 0.00% (As of Mar. 2026)


JBIO Jade Biosciences Inc JBIO
12 GF Score
Price $22.00
! 1 Warning Sign
View Full Analysis

What is Jade Biosciences OCF Margin %?

Jade Biosciences JBIO +0.87% 12 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates JBIO with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 958 Biotechnology companies, Jade Biosciences ranks worse than 104384.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Jade Biosciences's Cash Flow from Operations for the three months ended in Mar. 2026 was $-24.08 Mil. Jade Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Jade Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Jade Biosciences's current OCF Yield % is -7.47%.

The historical rank and industry rank for Jade Biosciences's OCF Margin % or its related term are showing as below:


JBIO's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Jade Biosciences OCF Margin % Related Terms

Jade Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Jade Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jade Biosciences OCF Margin % Chart

Jade Biosciences Annual Data
Trend Dec24 Dec25
OCF Margin %
0.00 0.00

Jade Biosciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
JBIO
12GF Score
Jade Biosciences Inc JBIO
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jade Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Jade Biosciences's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-94.689/0
= %

Jade Biosciences's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-24.081/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Jade Biosciences (JBIO) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jade Biosciences and its competitors. According to the industry distribution chart, Jade Biosciences ranks #999999 out of 958 companies in the Biotechnology industry.
Is Jade Biosciences' OCF Margin % too high?
Jade Biosciences' current OCF Margin % is 0.00%. Based on the distribution chart, Jade Biosciences ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jade Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Jade Biosciences' OCF Margin % compare to CRVS and ABSI?
According to the Biotechnology industry distribution chart, Jade Biosciences ranks #999999 out of 958 companies for OCF Margin %. This places Jade Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jade Biosciences and its competitors. Jade Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jade Biosciences stock overvalued right now?
Jade Biosciences (JBIO) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Jade Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Jade Biosciences (JBIO), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jade Biosciences Business Description

Address 221 Crescent Street, Building 23, Suite 105, Waltham, MA, USA, 02453
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
12GF Score

Get the complete analysis for JBIO

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price